4Hoofnagle JH, Doo E, Liang TJ, et al. Management of hepatitis B: summary of a clinical research workshop. Hepatology, 2007, 45: 1056-1075.
5Keeffe EB, Zeuzem S, Koff RS, et al. Report of an international workshop: Roadmap for management of patients receiving oral therapy for chronic hepatitis B. Clin Gastroenterol Hepatol, 2007, 5: 890-897.
6Lok AS, Zoulim F, Locarnini S, et al. Antiviral drug-resistant HBV: standardization of nomenclature and assays and recommendations for management. Hepatology, 2007, 46: 254-265.
7Pawlotsky JM, Dusheiko G, Hatzakis A, et al. Virologic monitoring of hepatitis B virus therapy in clinical trials and practice: recommendations for a standardized approach. Gastroenterology, 2008, 134: 405-415.
8Lok AS. I-IBV treatment in dications and efficacy of approved nucleoside/nucleotide inhibitors//EASL-AASLD-APASL-ALEH-IASL Conference: hepatitis B and C virus resistance to antiviral therapies, Pads, 2008. http://www.easl.ch/hepatitis-conference.
9Kew MC. Hepatitis viruses and hepatocellular carcinoma[ J]. Res Virol, 1998,149 : 257 - 262.
10Shafritz DA, Kew MC. Identification of integrated hepatitis B vires DNA sequences in human hepatocellular carcinoma[ J]. Hepatology ,1981,1:1-8.
4Yeo W, Chan PK, Zhong S, et al. Frequency of hepatitis B Virus reactivation in cancer patients undergoing cytotoxic chemotherapy:a prospective study of 626 patients with identification of risk factors[ J]. J Med Virol, 2000;62(3) :299- 307.
5Li N, Eric L, Shi J, et al. A comparative study of antiviral therapy after resection of hepatocellular carcinoma in the immune-active phase of hepatitis B virus infection[ J]. Surg Oucol,2010 ; 17 : 179-85.
6Piao CY, Shin-ichi Fujioka, Yoshiaki Iwasaki, et al. Lamivudine treatment in patients with HBV-related hepatocellular carcinoma-using an untreated,matched control cohort[ J]. Acta Medica Okayama,2005 ;59 (5) :217-24.
7Kuzuya Teiji, Katano Yoshiak, Kumada Takashi, et al. Efficacy of antiviral therapy with lamivudine after initial Treatment for hepatitis B virusrelated hepatocellular carcinoma [ J ]. J Gastroenterol Hepatol,2007 ;22 : 1929-35.
9EI-Serag HB,Rudolph KL.Hepatocellular carcinoma:epidemiology and molecular carcinogenensis.Gastroenterology,2007,132:2557- 2576.
10Yeo W,Chan PK,Zhong S,et al.Frequency of hepatitis B Virus reactivation in cancer patients undergoing cytotoxic chemotherapy: a prospective study of 626 patients with identification of risk factors.J Med Viro[,2000,62:299- 307.
